<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Biajoux, Vincent</dc:creator>
  <dc:creator>Bignon, Alexandre</dc:creator>
  <dc:creator>Freitas, Christelle</dc:creator>
  <dc:creator>Martinez, Valérie</dc:creator>
  <dc:creator>Thelen, Marcus</dc:creator>
  <dc:creator>Lima, Guadalupe</dc:creator>
  <dc:creator>Jakez-Ocampo, Juan</dc:creator>
  <dc:creator>Emilie, Dominique</dc:creator>
  <dc:creator>Llorente, Luis</dc:creator>
  <dc:creator>Balabanian, Karl</dc:creator>
  <dc:date>2012-12-18</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Background: Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease  characterized by B-cell hyperreactivity and the production of pathogenic anti-nuclear- directed auto-antibodies (Abs). B-cell ontogeny is partly dependent on the  CXCL12/CXCR4 axis for which the contribution to SLE pathogenesis remains unclear.  CXCR7, the novel receptor for CXCL12, is differentially expressed among memory B-cell  subsets. However, its biological role in SLE remains to be explored. Methods: Relative  CXCR4 and CXCR7 expression levels were compared by quantitative PCR in leukocytes  from blood samples of 41 Mexican Mestizos patients with SLE and 45 ethnicity-matched  healthy subjects. Intracellular and membrane expression of both receptors was analyzed  by flow cytometry in naive and Ab-secreting B cells. B-cell responsiveness to CXCL12 was  investigated using Transwell-based chemotaxis assays. Data were analyzed using the  Kruskal-Wallis test for comparisons of values amongst healthy controls and patients with  inactive or active SLE, and non-parametrically using the Mann–Whitney U-test for multiple  comparisons and unpaired samples. Correlations were determined by Spearman’s  ranking. Result: SLE leukocytes displayed reduced levels of CXCR4 and CXCR7  transcripts. In SLE patients, a significant defect in CXCR4 expression was detected at the  surface of naive and Ab-secreting B cells, associated with an abnormal intracellular  localization of the receptor. CXCR7 predominantly localized in cytosolic compartments of  B cells from healthy and SLE individuals. Disease activity did not impact on these  expression patterns. Altered receptor compartmentalization correlated with an impaired  CXCL12-promoted migration of SLE B cells. Conclusions: Our data highlight a down- regulation of CXCL12 receptors on circulating B cells from SLE patients that likely  influences their migratory behavior and distribution.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://localhost:5000/ark:/12658/srd1319156</dc:identifier>
  <dc:identifier>https://susi.usi.ch/global/documents/319156</dc:identifier>
  <dc:identifier>https://susi.usi.ch/documents/319156/files/Biajoux_JTM_2012.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1186/1479-5876-10-251</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/ark/12658/srd1319156</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>CC BY</dc:rights>
  <dc:source>Journal of translational medicine. - 2012, vol. 10, no. 1, p. 251-267</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Autoimmunity</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Systemic Lupus erythematosus</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">B cells</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">Chemokines</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">CXCR4</dc:subject>
  <dc:subject xmlns:ns6="xml" ns6:lang="en">CXCR7</dc:subject>
  <dc:subject xmlns:ns7="xml" ns7:lang="en">Migration</dc:subject>
  <dc:subject>info:eu-repo/classification/udc/61</dc:subject>
  <dc:title xmlns:ns8="xml" ns8:lang="en">Expression of CXCL12 receptors in B cells from Mexican Mestizos patients with systemic lupus erythematosus</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
